Evidence map›Paper›PMID 30799025›Full record

ArticleKidney international2019

Notch signaling in bone marrow-derived FSP-1 cells initiates neointima formation in arteriovenous fistulas.

Ming Liang, Qunying Guo, Fengzhang Huang, Guofeng Han, Ke Song, Jinlong Luo, Hunter Cheng, Hongzhen Hu, Eric K Peden, Changyi Chen and 5 more

Open access · greenAbstract read
In one paragraph

Article in Kidney international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. A Vein Attempt? Experimental Models for Arteriovenous Fistula Research.Cardiovascular engineering and technology · 2026
    Review
  2. Human Data First: New Biological Premises for Arteriovenous Fistula Research.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  3. Tenascin CNature communications · 2026
    Article
  4. Review
  5. The rodent models of arteriovenous fistula.Frontiers in cardiovascular medicine · 2024
    Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Ming LiangDepartment of Nephrology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China; Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Qunying GuoSelzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Fengzhang HuangSelzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Guofeng HanSelzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Ke SongSelzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Jinlong LuoSelzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Hunter ChengSelzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Hongzhen HuPain Center, Washington University, Saint Louis, Missouri, USA.
Eric K PedenDepartment of Vascular Surgery, DeBakey Heart and Vascular Institute, Houston Methodist Hospital, Houston, Texas, USA.
Changyi ChenMichael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.
William E MitchSelzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Jie DuBeijing AnZhen Hospital, Capital Medical University, The Key Laboratory of Remodeling-related Cardiovascular Diseases, Ministry of Education, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
Xiaodong FuDepartment of Nephrology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China.
Luan TruongDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Methodist Hospital Research Institute, Houston, Texas, USA.
Jizhong ChengSelzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA. Electronic address: jizhongc@bcm.edu.
Baylor College of Medicine · USCapital Medical University · CNGuangzhou First People's Hospital · CNGuangzhou Medical University · CNHouston Methodist · USMethodist Hospital · USWashington University in St. Louis · US

Funding

PROTEIN NUTRITION IN EXPERIMENTAL UREMIAR01DK037175 · NIDDK · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Zhaoyong Hu · 1986 to 2026
$4.3M
PROTEIN NUTRITION IN EXPERIMENTAL UREMIAR37DK037175 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI MITCH, WILLIAM EVANS · 2006 to 2015
$3.8M
TARGETING THE TRANSIENT RECEPTOR POTENTIAL CHANNELS TO IMPROVE BOWEL DYSFUNCTIONR01DK103901 · NIDDK · WASHINGTON UNIVERSITY · PI HU, HONGZHEN · 2015 to 2023
$3.4M
MECHANISMS OF TRPV4-MEDIATED NEUROPATHIC PAINR01AA027065 · NIAAA · WASHINGTON UNIVERSITY · PI HU, HONGZHEN · 2018 to 2022
$2.5M
CHRONIC KIDNEY DISEASE ADVERSELY INFLUENCES VASCULAR FUNCTIONSR01DK095867 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI CHENG, JIZHONG · 2013 to 2017
$1.7M
Mechanisms of Zinc Regulation of Pain-initiating TRP ChannelsR01GM101218 · NIGMS · WASHINGTON UNIVERSITY · PI HU, HONGZHEN · 2013 to 2017
$1.4M
NIAAA NIH HHS R01 AA027065NIDDK NIH HHS R01 DK037175NIDDK NIH HHS R01 DK095867NIDDK NIH HHS R37 DK037175NIGMS NIH HHS R01 GM101218
6 · The paper itself

Abstract

Neointima formation is a major contributor to arteriovenous fistula (AVF) failure. We have previously shown that activation of the Notch signaling pathway contributes to neointima formation by promoting the migration of vascular smooth muscle cells (VSMCs) into the venous anastomosis. In the current study we investigated the mechanisms underlying the dedifferentiation and migration of VSMCs, and in particular the role of bone marrow-derived fibroblast specific protein 1 (FSP-1)

Indexed as

AnimalsArteriovenous Shunt, SurgicalCell DedifferentiationCells, CulturedDisease Models, AnimalHumansImmunoglobulin J Recombination Signal Sequence-Binding ProteinMacrophagesMaleMiceMice, KnockoutMuscle, Smooth, VascularMyocytes, Smooth MuscleNeointimaPrimary Cell CultureReceptors, NotchImmunoglobulin J Recombination Signal Sequence-Binding ProteinRbpj protein, mouseReceptors, NotchS100a4 protein, mouseS100 Calcium-Binding Protein A4arteriovenous fistuladedifferentiationfibroblast specific protein 1Notch signalingvascular smooth muscle cell

Identifiers

PMID30799025
PMCPMC6763204
OpenAlexW2916508208

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.